INSTADOSE PHARMA CORP. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

On June 10, 2021, Instadose Pharma Corp. (the "Company"), filed with the Secretary of State of the State of Nevada an amendment to its articles of incorporation (the "Amendment") to increase the authorized common stock from 500,000,000 shares to 700,000,000 shares, par value $.0001 per share, The Amendment also authorized the Company to issue up to 1,000,000 shares of blank check preferred stock, par value $0001 per share. The Amendment will become effective upon the filing of the Amendment with the Nevada Secretary of State. The Amendment was filed following approval by the majority of the shareholders of the Company without a formality of convening a meeting pursuant to the written consent as further described in Item 5.07 below.

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 10, 2021, the shareholder(s) holding an aggregate of 50,000,000 shares, representing 66.6% of the issued and outstanding shares of the Company, executed a written consent approving the Amendment.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the complete text of the Amendment, a copy of which is filed with this Current Report on Form 8-K as Exhibit 3.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit No.   Description
  3.1           Certificate of amendment to the Articles of Incorporation of the
              Company.





2

© Edgar Online, source Glimpses